Hypertension in Thoracic Aortic Dissection: A Meta-Analysis-Based Consideration in the Choice of Antihypertensive Agents
American Journal of Hypertension · 2026
DOI: 10.1093/ajh/hpaf132 ↗Kurz gefasst
Metaanalyse in der Zeitschrift American Journal of Hypertension, 2026. Verfasst von Sohat Sharma und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of British Columbia, Vancouver, Canada. Hauptthemen laut MEDLINE: Antihypertensive Agents, Aortic Dissection, Hypertension, Aortic Aneurysm, Thoracic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND Thoracic aortic dissection (TAD) is a potentially fatal condition. It has been linked with hypertension, and guidelines recommend antihypertensives. METHODS Electronic searches were conducted in MEDLINE and EMBASE with the following search strategy: ((“thoracic aortic dissection”[Mesh]) AND (“antihypertensive agents”[Mesh] from database inception to August 2024. RESULTS Hypertension is associated with a significant risk of TAD with a hazard ratio (HR) of 2.51 (95% CI: 1.75–3.60). Beta-blocker treatment produces a significant (P < 0.01) lower risk of an MACE HR of 0.55 (95% CI = 0.39-0.77). Angiotensin receptor blockers (ARBs) or ACE inhibitors also lower the risk of a major adverse cardiac event with a HR of 0.67 (95% CI = 0.58–0.78). Calcium channel blockers (CCB) significantly (P =0.0007) lowered MACE outcomes with a HR of 0.66 (95% CI = 0.53–0.84). A network meta-analysis was performed to evaluate the relative risk of aortic events associated with commonly prescribed antihypertensive agents, using beta-blockers (BB) as the reference comparator. Compared to BB, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACE/ARB) were associated with a non-significant increase in risk (HR 1.28, 95% confidence interval (CI): 0.91–1.81). CCB also demonstrated a non-significant reduction in risk (HR 0.68, 95% CI: 0.33–1.40) to BBs. CONCLUSIONS Hypertension is strongly associated with a risk of TAD. Beta-blockers are associated with the greatest reduction in MACE and remain the most effective first-line therapy for patients at risk of TAD. ACE inhibitors and ARBs also demonstrate benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of British Columbia, Vancouver, Canada.
- Division of Cardiology, Department of Medicine, University of British Columbia, Vancouver, Canada.
Zitieren
APA
Sharma, S., Seth, J., & Rabkin, S. W. (2026). Hypertension in Thoracic Aortic Dissection: A Meta-Analysis-Based Consideration in the Choice of Antihypertensive Agents. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpaf132
Vancouver
Sharma S, Seth J, Rabkin SW. Hypertension in Thoracic Aortic Dissection: A Meta-Analysis-Based Consideration in the Choice of Antihypertensive Agents. American Journal of Hypertension. 2026. doi:10.1093/ajh/hpaf132
BibTeX
@article{Sharma2026,
author = {Sharma, Sohat and Seth, Jayant and Rabkin, Simon W},
title = {Hypertension in Thoracic Aortic Dissection: A Meta-Analysis-Based Consideration in the Choice of Antihypertensive Agents},
journal = {American Journal of Hypertension},
year = {2026},
doi = {10.1093/ajh/hpaf132}
}
EUVIMED